Simplex Trading’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-25
Closed -$1K 8453
2018
Q4
$1K Buy
+25
New +$26 ﹤0.01% 6879
2018
Q2
Sell
-288
Closed -$95K 8373
2018
Q1
$95K Buy
288
+2
+0.7% +$4 ﹤0.01% 1849
2017
Q4
$76K Buy
286
+156
+120% +$395 ﹤0.01% 2050
2017
Q3
$12K Sell
130
-417
-76% -$1.4K ﹤0.01% 3657
2017
Q2
$17K Sell
547
-65
-11% -$214 ﹤0.01% 3500
2017
Q1
$43K Buy
612
+605
+8,643% +$2.35K ﹤0.01% 2522
2016
Q4
$2K Buy
+7
New +$29 ﹤0.01% 5265

Simplex Trading's AST Position: Q1 2019 in Review

Simplex Trading sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q1 2019, closing a stake of 1,842 shares — an estimated $1K sold.

Simplex Trading first reported a position in AST in Q1 2017 and held it in 6 quarters. The position peaked at $58K in Q1 2017. 0 funds tracked by Wall St. Rank hold AST as of Q1 2019.

  • Simplex Trading reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q1 2019 after selling out during the quarter.
  • Simplex Trading sold 1,842 Asterias Biotherapeutics Inc. Series A shares in Q1 2019, an estimated $1K.
  • Simplex Trading first reported a position in Asterias Biotherapeutics Inc. Series A in Q1 2017 and held it in 6 quarters.
  • Simplex Trading's Asterias Biotherapeutics Inc. Series A position peaked at $58K in Q1 2017.
  • 0 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q1 2019.

Based on Simplex Trading's 13F filing for Q1 2019, filed 18 Apr 2019.